Cartilage tissue engineering: Towards a biomaterial-assisted mesenchymal stem cell therapy

Current Stem Cell Research and Therapy

Volumn 4, Issue 4, 2009, Pages 318-329

  Vinatier, Claire ^a,b,f   Bouffi, Carine ^c,d   Merceron, Christophe ^a,b   Gordeladze, Jan ^c,d   Brondello, Jean Marc ^c,d   Jorgensen, Christian ^c,d,e   Weiss, Pierre ^a,b   Guicheux, Jérome ^a,b   Noël, Danièle ^c,d  

^a Universite de Nantes   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c INSERM   (France)

^d UNIV MONTPELLIER   (France)

^e LAPEYRONIE HOSPITAL   (France)

^f GRAFTYS SAS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGAROSE; ALGINIC ACID; BIOMATERIAL; BONE MORPHOGENETIC PROTEIN; CARBON FIBER; CELLULOSE; CHITOSAN; COLLAGEN; DACRON; FIBRIN; FIBRIN GLUE; FIBROBLAST GROWTH FACTOR; GELATIN; HYALURONIC ACID; LAMININ; POLITEF; POLYLACTIC ACID; SOMATOMEDIN C; SONIC HEDGEHOG PROTEIN; TISSUE SCAFFOLD; TRANSFORMING GROWTH FACTOR BETA; WNT1 PROTEIN;

ABRASION ARTHROPLASTY; ARTICULAR CARTILAGE; BIOCOMPATIBILITY; CARTILAGE CELL; CARTILAGE INJURY; CELL DIFFERENTIATION; CHONDROCYTE IMPLANTATION; HUMAN; HYDROGEL; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROFRACTURE; MOSAICPLASTY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; TISSUE ENGINEERING;

ANIMALS; BIOCOMPATIBLE MATERIALS; CARTILAGE; CARTILAGE DISEASES; CELL DIFFERENTIATION; CHONDROCYTES; GUIDED TISSUE REGENERATION; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MESENCHYMAL STEM CELL TRANSPLANTATION; STEM CELL NICHE; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 74849098553     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488809789649205     Document Type: Review

References (171)

1. Alsalameh S, Amin R, Gemba T, Lotz M. Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage. Arthritis Rheum 2004; 50: 1522-32.
2. Poole AR, Kojima T, Yasuda T, Mwale F, Kobayashi M, Laverty S. Composition and structure of articular cartilage: a template for tissue repair. Clin Orthop Relat Res 2001: 391(Suppl): S26-33.
3. Goldring MB. Update on the biology of the chondrocyte and new approaches to treating cartilage diseases. Best Pract Res Clin Rheumatol 2006; 20: 1003-25.
4. Smith GD, Knutsen G, Richardson JB. A clinical review of cartilage repair techniques. J Bone Joint Surg Br 2005; 87: 445-9.
5. Klein TJ, Schumacher BL, Schmidt TA, et al. Tissue engineering of stratified articular cartilage from chondrocyte subpopulations. Osteoarthritis Cartilage 2003; 11: 595-602.
6. Kuroda R, Ishida K, Matsumoto T, et al. Treatment of a fullthickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells. Osteoarthritis Cartilage 2007; 15: 226-31.
7. Wood JJ, Malek MA, Frassica FJ, et al. Autologous cultured chondrocytes: adverse events reported to the United States Food and Drug Administration. J Bone Joint Surg Am 2006; 88: 503-7.
8. Isogai N, Kusuhara H, Ikada Y, et al. Comparison of different chondrocytes for use in tissue engineering of cartilage model structures. Tissue Eng 2006; 12: 691-703.
9. Kafienah W, Jakob M, Demarteau O, et al. Three-dimensional tissue engineering of hyaline cartilage: comparison of adult nasal and articular chondrocytes. Tissue Eng 2002; 8: 817-26.
10. Darling EM, Athanasiou KA. Rapid phenotypic changes in passaged articular chondrocyte subpopulations. J Orthop Res 2005; 23: 425-32.
11. Schnabel M, Marlovits S, Eckhoff G, et al. Dedifferentiationassociated changes in morphology and gene expression in primary human articular chondrocytes in cell culture. Osteoarthritis Cartilage 2002; 10: 62-70.
12. Domm C, Schunke M, Christesen K, Kurz B. Redifferentiation of dedifferentiated bovine articular chondrocytes in alginate culture under low oxygen tension. Osteoarthritis Cartilage 2002; 10: 13-22.
13. Malda J, van Blitterswijk CA, Grojec M, Martens DE, Tramper J, Riesle J. Expansion of bovine chondrocytes on microcarriers enhances redifferentiation. Tissue Eng 2003; 9: 939-48.
14. Fukui N, Purple CR, Sandell LJ. Cell biology of osteoarthritis: the chondrocyte's response to injury. Curr Rheumatol Rep 2001; 3: 496-505.
15. Sandell LJ, Aigner T. Articular cartilage and changes in arthritis. An introduction: cell biology of osteoarthritis. Arthritis Res 2001; 3: 107-13.
16. Tallheden T, Bengtsson C, Brantsing C, et al. Proliferation and differentiation potential of chondrocytes from osteoarthritic patients. Arthritis Res Ther 2005; 7: R560-8.
17. Chen Y, Shao JZ, Xiang LX, Dong XJ, Zhang GR. Mesenchymal stem cells: a promising candidate in regenerative medicine. Int J Biochem Cell Biol 2008; 40: 815-20.
18. Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 1970; 3: 393-403.
19. Gronthos S, Simmons PJ. The biology and application of human bone marrow stromal cell precursors. J Hematother 1996; 5: 15-23.
20. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315-7.
21. Pittenger M, Vanguri P, Simonetti D, Young R. Adult mesenchymal stem cells: potential for muscle and tendon regeneration and use in gene therapy. J Musculoskelet Neuronal Interact 2002; 2: 309-20.
22. Makino S, Fukuda K, Miyoshi S, et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 1999; 103: 697-705.
23. Phinney DG, Isakova I. Plasticity and therapeutic potential of mesenchymal stem cells in the nervous system. Curr Pharm Des 2005; 11: 1255-65.
24. Tropel P, Platet N, Platel JC, et al. Functional neuronal differentiation of bone marrow-derived mesenchymal stem cells. Stem Cells 2006; 24: 2868-76.
25. Bhatia R, Hare JM. Mesenchymal stem cells: future source for reparative medicine. Congest Heart Fail 2005; 11: 87-91; quiz 92-83.
26. Noel D, Djouad F, Bouffi C, Mrugala D, Jorgensen C. Multipotent mesenchymal stromal cells and immune tolerance. Leuk Lymphoma 2007; 48: 1283-9.
27. Reyes M, Lund T, Lenvik T, Aguiar D, Koodie L, Verfaillie CM. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 2001; 98: 2615-25.
28. D'Ippolito G, Diabira S, Howard GA, Menei P, Roos BA, Schiller PC. Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci 2004; 117: 2971-81.
29. Grimaud E, Heymann D, Redini F. Recent advances in TGF-beta effects on chondrocyte metabolism. Potential therapeutic roles of TGF-beta in cartilage disorders. Cytokine Growth Factor Rev 2002; 13: 241-57.
30. Mackay AM, Beck SC, Murphy JM, Barry FP, Chichester CO, Pittenger MF. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng 1998; 4: 415-28.
31. Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 1998; 238: 265-72.
32. Facchini A, Lisignoli G, Cristino S, et al. Human chondrocytes and mesenchymal stem cells grown onto engineered scaffold. Biorheology 2006; 43: 471-80.
33. Park JS, Woo DG, Yang HN, Lim HJ, Chung HM, Park KH. Heparin-bound transforming growth factor-beta3 enhances neocartilage formation by rabbit mesenchymal stem cells. Transplantation 2008; 85: 589-96.
34. Fan H, Hu Y, Li X, et al. Ectopic cartilage formation induced by mesenchymal stem cells on porous gelatin-chondroitin-hyaluronate scaffold containing microspheres loaded with TGF-beta1. Int J Artif Organs 2006; 29: 602-11.
35. Glansbeek HL, van Beuningen HM, Vitters EL, van der Kraan PM, van den Berg WB. Stimulation of articular cartilage repair in established arthritis by local administration of transforming growth factor-beta into murine knee joints. Lab Invest 1998; 78: 133-42.
36. van Beuningen HM, van der Kraan PM, Arntz OJ, van den Berg WB. Transforming growth factor-beta 1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint. Lab Invest 1994; 71: 279-90.
37. Blaney Davidson EN, Vitters EL, van Beuningen HM, van de Loo FA, van den Berg WB, van der Kraan PM. Resemblance of osteophytes in experimental osteoarthritis to transforming growth factor beta-induced osteophytes: limited role of bone morphogenetic protein in early osteoarthritic osteophyte formation. Arthritis Rheum 2007; 56: 4065-73.
38. Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors 2004; 22: 233-41.
39. Majumdar MK, Wang E, Morris EA. BMP-2 and BMP-9 promotes chondrogenic differentiation of human multipotential mesenchymal cells and overcomes the inhibitory effect of IL-1. J Cell Physiol 2001; 189: 275-84.
40. Gruber R, Mayer C, Bobacz K, et al. Effects of cartilage-derived morphogenetic proteins and osteogenic protein-1 on osteochondrogenic differentiation of periosteum-derived cells. Endocrinology 2001; 142: 2087-94.
41. Jorgensen C, Gordeladze J, Noel D. Tissue engineering through autologous mesenchymal stem cells. Curr Opin Biotechnol 2004; 15: 406-10.
42. Sekiya I, Larson BL, Vuoristo JT, Reger RL, Prockop DJ. Comparison of effect of BMP-2, -4, and -6 on in vitro cartilage formation of human adult stem cells from bone marrow stroma. Cell Tissue Res 2005; 320: 269-76.
43. Grunder T, Gaissmaier C, Fritz J, et al. Bone morphogenetic protein (BMP)-2 enhances the expression of type II collagen and aggrecan in chondrocytes embedded in alginate beads. Osteoarthritis Cartilage 2004; 12: 559-67.
44. Kuo AC, Rodrigo JJ, Reddi AH, Curtiss S, Grotkopp E, Chiu M. Microfracture and bone morphogenetic protein 7 (BMP-7) synergistically stimulate articular cartilage repair. Osteoarthritis Cartilage 2006; 14: 1126-35.
45. Kuroda R, Usas A, Kubo S, et al. Cartilage repair using bone morphogenetic protein 4 and muscle-derived stem cells. Arthritis Rheum 2006; 54: 433-42.
46. Gelse K, Muhle C, Franke O, et al. Cell-based resurfacing of large cartilage defects: long-term evaluation of grafts from autologous transgene-activated periosteal cells in a porcine model of osteoarthritis. Arthritis Rheum 2008; 58: 475-88.
47. Noel D, Gazit D, Bouquet C, et al. Short-term BMP-2 expression is sufficient for in vivo osteochondral differentiation of mesenchymal stem cells. Stem Cells 2004; 22: 74-85.
48. Hannallah D, Peng H, Young B, Usas A, Gearhart B, Huard J. Retroviral delivery of Noggin inhibits the formation of heterotopic ossification induced by BMP-4, demineralized bone matrix, and trauma in an animal model. J Bone Joint Surg Am 2004; 86-A: 80-91.
49. Peng H, Usas A, Hannallah D, Olshanski A, Cooper GM, Huard J. Noggin improves bone healing elicited by muscle stem cells expressing inducible BMP4. Mol Ther 2005; 12: 239-46.
50. Kikuchi A, Yamamoto H, Kishida S. Multiplicity of the interactions of Wnt proteins and their receptors. Cell Signal 2007; 19: 659-71.
51. Macsai CE, Foster BK, Xian CJ. Roles of Wnt signalling in bone growth, remodelling, skeletal disorders and fracture repair. J Cell Physiol 2008; 215: 578-87.
52. Church V, Nohno T, Linker C, Marcelle C, Francis-West P. Wnt regulation of chondrocyte differentiation. J Cell Sci 2002; 115: 4809-18.
53. Rudnicki JA, Brown AM. Inhibition of chondrogenesis by Wnt gene expression in vivo and in vitro. Dev Biol 1997; 185: 104-18.
54. Andrade AC, Nilsson O, Barnes KM, Baron J. Wnt gene expression in the post-natal growth plate: regulation with chondrocyte differentiation. Bone 2007; 40: 1361-9.
55. Day TF, Guo X, Garrett-Beal L, Yang Y. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 2005; 8: 739-50.
56. Hill TP, Spater D, Taketo MM, Birchmeier W, Hartmann C. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell 2005; 8: 727-38.
57. Chen Y, Whetstone HC, Youn A, et al. Beta-catenin signaling pathway is crucial for bone morphogenetic protein 2 to induce new bone formation. J Biol Chem 2007; 282: 526-33.
58. Ornitz DM, Itoh N. Fibroblast growth factors. Genome Biol 2001; 2: REVIEWS3005.
59. Liu Z, Xu J, Colvin JS, Ornitz DM. Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes Dev 2002; 16: 859-69.
60. Ornitz DM. FGF signaling in the developing endochondral skeleton. Cytokine Growth Factor Rev 2005; 16: 205-13.
61. Hoffmann A, Czichos S, Kaps C, et al. The T-box transcription factor Brachyury mediates cartilage development in mesenchymal stem cell line C3H10T1/2. J Cell Sci 2002; 115: 769-81.
62. Davidson D, Blanc A, Filion D, et al. Fibroblast growth factor (FGF) 18 signals through FGF receptor 3 to promote chondrogenesis. J Biol Chem 2005; 280: 20509-15.
63. Weizmann S, Tong A, Reich A, Genina O, Yayon A, Monsonego-Ornan E. FGF upregulates osteopontin in epiphyseal growth plate chondrocytes: implications for endochondral ossification. Matrix Biol 2005; 24: 520-9.
64. Solchaga LA, Penick K, Porter JD, Goldberg VM, Caplan AI, Welter JF. FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J Cell Physiol 2005; 203: 398-409.
65. Stewart AA, Byron CR, Pondenis H, Stewart MC. Effect of fibroblast growth factor-2 on equine mesenchymal stem cell monolayer expansion and chondrogenesis. Am J Vet Res 2007; 68: 941-5.
66. Takafuji H, Suzuki T, Okubo Y, Fujimura K, Bessho K. Regeneration of articular cartilage defects in the temporomandibular joint of rabbits by fibroblast growth factor-2: a pilot study. Int J Oral Maxillofac Surg 2007; 36: 934-7.
67. Ishii I, Mizuta H, Sei A, Hirose J, Kudo S, Hiraki Y. Healing of full-thickness defects of the articular cartilage in rabbits using fibroblast growth factor-2 and a fibrin sealant. J Bone Joint Surg Br 2007; 89: 693-700.
68. Moore EE, Bendele AM, Thompson DL, et al. Fibroblast growth factor-18 stimulates chondrogenesis and cartilage repair in a rat model of injury-induced osteoarthritis. Osteoarthritis Cartilage 2005; 13: 623-31.
69. Dupont J, Holzenberger M. Biology of insulin-like growth factors in development. Birth Defects Res C Embryo Today 2003; 69: 257-71.
70. Woods KA, Camacho-Hubner C, Savage MO, Clark AJ. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 1996; 335: 1363-7.
71. Davies LC, Blain EJ, Gilbert SJ, Caterson B, Duance VC. The potential of IGF-1 and TGFbeta1 for promoting "adult" articular cartilage repair: An In vitro Study. Tissue Eng Part A 2008.
72. Yoon DM, Fisher JP. Effects of exogenous IGF-1 delivery on the early expression of IGF-1 signaling molecules by alginate embedded chondrocytes. Tissue Eng Part A 2008; 14: 1263-73.
73. Uebersax L, Merkle HP, Meinel L. Insulin-like growth factor I releasing silk fibroin scaffolds induce chondrogenic differentiation of human mesenchymal stem cells. J Control Release 2008; 127: 12-21.
74. Schmidt MB, Chen EH, Lynch SE. A review of the effects of insulin-like growth factor and platelet derived growth factor on in vivo cartilage healing and repair. Osteoarthritis Cartilage 2006; 14: 403-12.
75. Long F, Zhang XM, Karp S, Yang Y, McMahon AP. Genetic manipulation of hedgehog signaling in the endochondral skeleton reveals a direct role in the regulation of chondrocyte proliferation. Development 2001; 128: 5099-108.
76. Ehlen HW, Buelens LA, Vortkamp A. Hedgehog signaling in skeletal development. Birth Defects Res C Embryo Today 2006; 78: 267-79.
77. Warzecha J, Gottig S, Bruning C, Lindhorst E, Arabmothlagh M, Kurth A. Sonic hedgehog protein promotes proliferation and chondrogenic differentiation of bone marrow-derived mesenchymal stem cells in vitro. J Orthop Sci 2006; 11: 491-6.
78. Fontaine C, Cousin W, Plaisant M, Dani C, Peraldi P. Hedgehog signaling alters adipocyte maturation of human mesenchymal stem cells. Stem Cells 2008; 26: 1037-46.
79. Edwards PC, Ruggiero S, Fantasia J, et al. Sonic hedgehog geneenhanced tissue engineering for bone regeneration. Gene Ther 2005; 12: 75-86.
80. Nesic D, Whiteside R, Brittberg M, Wendt D, Martin I, Mainil-Varlet P. Cartilage tissue engineering for degenerative joint disease. Adv Drug Deliv Rev 2006; 58: 300-22.
81. Drury JL, Mooney DJ. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials 2003; 24: 4337-51.
82. Lubiatowski P, Kruczynski J, Gradys A, Trzeciak T, Jaroszewski J. Articular cartilage repair by means of biodegradable scaffolds. Transplant Proc 2006; 38: 320-2.
83. Wakitani S, Goto T, Young RG, Mansour JM, Goldberg VM, Caplan AI. Repair of large full-thickness articular cartilage defects with allograft articular chondrocytes embedded in a collagen gel. Tissue Eng 1998; 4: 429-44.
84. Lee CR, Grodzinsky AJ, Hsu HP, Spector M. Effects of a cultured autologous chondrocyte-seeded type II collagen scaffold on the healing of a chondral defect in a canine model. J Orthop Res 2003; 21: 272-81.
85. Wakitani S, Goto T, Pineda SJ, et al. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg Am 1994; 76: 579-92.
86. McCoy JP, Jr., Schade WJ, Siegle RJ, Waldinger TP, Vanderveen EE, Swanson NA. Characterization of the humoral immune response to bovine collagen implants. Arch Dermatol 1985; 121: 990-4.
87. Ochi M, Uchio Y, Kawasaki K, Wakitani S, Iwasa J. Transplantation of cartilage-like tissue made by tissue engineering in the treatment of cartilage defects of the knee. J Bone Joint Surg Br 2002; 84: 571-8.
88. Schneider U, Andereya S. First results of a prospective randomized clinical trial on traditional chondrocyte transplantation vs CaReSTechnology. Z Orthop Ihre Grenzgeb 2003; 141: 496-7.
89. Sims CD, Butler PE, Cao YL, et al. Tissue engineered neocartilage using plasma derived polymer substrates and chondrocytes. Plast Reconstr Surg 1998; 101: 1580-5.
90. Hunziker EB. Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. Osteoarthritis Cartilage 2002; 10: 432-63
91. Fussenegger M, Meinhart J, Hobling W, Kullich W, Funk S, Bernatzky G. Stabilized autologous fibrin-chondrocyte constructs for cartilage repair in vivo. Ann Plast Surg 2003; 51: 493-8.
92. Peretti GM, Randolph MA, Villa MT, Buragas MS, Yaremchuk MJ. Cell-based tissue-engineered allogeneic implant for cartilage repair. Tissue Eng 2000; 6: 567-76.
93. van Susante JL, Buma P, Schuman L, Homminga GN, van den Berg WB, Veth RP. Resurfacing potential of heterologous chondrocytes suspended in fibrin glue in large full-thickness defects of femoral articular cartilage: an experimental study in the goat. Biomaterials 1999; 20: 1167-75.
94. Vinatier C, Gauthier O, Masson M, et al. Nasal chondrocytes and fibrin sealant for cartilage tissue engineering. J Biomed Mater Res A 2009; 89: 176-85.
95. Hendrickson DA, Nixon AJ, Grande DA, et al. Chondrocyte-fibrin matrix transplants for resurfacing extensive articular cartilage defects. J Orthop Res 1994; 12: 485-97.
96. Wilke MM, Nydam DV, Nixon AJ. Enhanced early chondrogenesis in articular defects following arthroscopic mesenchymal stem cell implantation in an equine model. J Orthop Res 2007; 25: 913-25.
97. Peterson L, Brittberg M, Kiviranta I, Akerlund EL, Lindahl A. Autologous chondrocyte transplantation. Biomechanics and longterm durability. Am J Sports Med 2002; 30: 2-12.
98. Awad HA, Wickham MQ, Leddy HA, Gimble JM, Guilak F. Chondrogenic differentiation of adipose-derived adult stem cells in agarose, alginate, and gelatin scaffolds. Biomaterials 2004; 25: 3211-22.
99. Diduch DR, Jordan LC, Mierisch CM, Balian G. Marrow stromal cells embedded in alginate for repair of osteochondral defects. Arthroscopy 2000; 16: 571-7.
100. Rahfoth B, Weisser J, Sternkopf F, Aigner T, von der Mark K, Brauer R. Transplantation of allograft chondrocytes embedded in agarose gel into cartilage defects of rabbits. Osteoarthritis Cartilage 1998; 6: 50-65.
101. Bonaventure J, Kadhom N, Cohen-Solal L, et al. Reexpression of cartilage-specific genes by dedifferentiated human articular chondrocytes cultured in alginate beads. Exp Cell Res 1994; 212: 97-104.
102. Carossino AM, Recenti R, Carossino R, et al. Methodological models for in vitro amplification and maintenance of human articular chondrocytes from elderly patients. Biogerontology 2007.
103. Almqvist KF, Wang L, Wang J, et al. Culture of chondrocytes in alginate surrounded by fibrin gel: characteristics of the cells over a period of eight weeks. Ann Rheum Dis 2001; 60: 781-90.
104. Erickson GR, Gimble JM, Franklin DM, Rice HE, Awad H, Guilak F. Chondrogenic potential of adipose tissue-derived stromal cells in vitro and in vivo. Biochem Biophys Res Commun 2002; 290: 763-9.
105. Fragonas E, Valente M, Pozzi-Mucelli M, et al. Articular cartilage repair in rabbits by using suspensions of allogenic chondrocytes in alginate. Biomaterials 2000; 21: 795-801.
106. Mierisch CM, Wilson HA, Turner MA, et al. Chondrocyte transplantation into articular cartilage defects with use of calcium alginate: the fate of the cells. J Bone Joint Surg Am 2003; 85-A: 1757-67.
107. Paige KT, Cima LG, Yaremchuk MJ, Schloo BL, Vacanti JP, Vacanti CA. De novo cartilage generation using calcium alginatechondrocyte constructs. Plast Reconstr Surg 1996; 97: 168-178; discussion 179-80.
108. Selmi TA, Verdonk P, Chambat P, et al. Autologous chondrocyte implantation in a novel alginate-agarose hydrogel: outcome at two years. J Bone Joint Surg Br 2008; 90: 597-604.
109. Knudson W, Casey B, Nishida Y, Eger W, Kuettner KE, Knudson CB. Hyaluronan oligosaccharides perturb cartilage matrix homeostasis and induce chondrocytic chondrolysis. Arthritis Rheum 2000; 43: 1165-74.
110. Tognana E, Padera RF, Chen F, Vunjak-Novakovic G, Freed LE. Development and remodeling of engineered cartilage-explant composites in vitro and in vivo. Osteoarthritis Cartilage 2005; 13: 896-905.
111. Goa KL, Benfield P. Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing. Drugs 1994; 47: 536-66.
112. Bulpitt P, Aeschlimann D. New strategy for chemical modification of hyaluronic acid: preparation of functionalized derivatives and their use in the formation of novel biocompatible hydrogels. J Biomed Mater Res 1999; 47: 152-69.
113. Chang CH, Liu HC, Lin CC, Chou CH, Lin FH. Gelatinchondroitin-hyaluronan tri-copolymer scaffold for cartilage tissue engineering. Biomaterials 2003; 24: 4853-8.
114. Marcacci M, Berruto M, Brocchetta D, et al. Articular cartilage engineering with Hyalograft C: 3-year clinical results. Clin Orthop Relat Res 2005; (435): 96-105.
115. Montembault A, Tahiri K, Korwin-Zmijowska C, Chevalier X, Corvol MT, Domard A. A material decoy of biological media based on chitosan physical hydrogels: application to cartilage tissue engineering. Biochimie 2006; 88: 551-64.
116. Di Martino A, Sittinger M, Risbud MV. Chitosan: a versatile biopolymer for orthopaedic tissue-engineering. Biomaterials 2005; 26: 5983-90.
117. Hoemann CD, Sun J, Legare A, McKee MD, Buschmann MD. Tissue engineering of cartilage using an injectable and adhesive chitosan-based cell-delivery vehicle. Osteoarthritis Cartilage 2005; 13: 318-29.
118. Muller FA, Muller L, Hofmann I, Greil P, Wenzel MM, Staudenmaier R. Cellulose-based scaffold materials for cartilage tissue engineering. Biomaterials 2006; 27: 3955-63.
119. Martson M, Viljanto J, Laippala P, Saukko P. Connective tissue formation in subcutaneous cellulose sponge implants in the rat. The effect of the size and cellulose content of the implant. Eur Surg Res 1998; 30: 419-25.
120. Andrews GP, Gorman SP, Jones DS. Rheological characterisation of primary and binary interactive bioadhesive gels composed of cellulose derivatives designed as ophthalmic viscosurgical devices. Biomaterials 2005; 26: 571-80.
121. Vinatier C, Gauthier O, Fatimi A, et al. An injectable cellulosebased hydrogel for the transfer of autologous nasal chondrocytes in articular cartilage defects. Biotechnol Bioeng 2009; 102: 1259-67.
122. Sittinger M, Reitzel D, Dauner M, et al. Resorbable polyesters in cartilage engineering: affinity and biocompatibility of polymer fiber structures to chondrocytes. J Biomed Mater Res 1996; 33: 57-63.
123. Spain TL, Agrawal CM, Athanasiou KA. New technique to extend the useful life of a biodegradable cartilage implant. Tissue Eng 1998; 4: 343-52.
124. Galois L, Freyria AM, Herbage D, Mainard D. [Cartilage tissue engineering: state-of-the-art and future approaches]. Pathol Biol (Paris) 2005; 53: 590-8.
125. Wang X, Grogan SP, Rieser F, et al. Tissue engineering of biphasic cartilage constructs using various biodegradable scaffolds: an in vitro study. Biomaterials 2004; 25: 3681-8.
126. Freed LE, Vunjak-Novakovic G, Langer R. Cultivation of cellpolymer cartilage implants in bioreactors. J Cell Biochem 1993; 51: 257-64.
127. Freed LE, Grande DA, Lingbin Z, Emmanual J, Marquis JC, Langer R. Joint resurfacing using allograft chondrocytes and synthetic biodegradable polymer scaffolds. J Biomed Mater Res 1994; 28: 891-9.
128. Ossendorf C, Kaps C, Kreuz PC, Burmester GR, Sittinger M, Erggelet C. Treatment of posttraumatic and focal osteoarthritic cartilage defects of the knee with autologous polymer-based threedimensional chondrocyte grafts: Two year clinical results. Arthritis Res Ther 2007; 9: R41.
129. Carranza-Bencano A, Armas-Padron JR, Gili-Miner M, Lozano MA. Carbon fiber implants in osteochondral defects of the rabbit patella. Biomaterials 2000; 21: 2171-6.
130. Messner K. Hydroxylapatite supported Dacron plugs for repair of isolated full-thickness osteochondral defects of the rabbit femoral condyle: mechanical and histological evaluations from 6-48 weeks. J Biomed Mater Res 1993; 27: 1527-32.
131. Messner K. Durability of artificial implants for repair of osteochondral defects of the medial femoral condyle in rabbits. Biomaterials 1994; 15: 657-64.
132. Defrere J, Franckart A. Teflon/polyurethane arthroplasty of the knee: the first 2 years preliminary clinical experience in a new concept of artificial resurfacing of full thickness cartilage lesions of the knee. Acta Chir Belg 1992; 92: 217-27.
133. Sontjens SH, Nettles DL, Carnahan MA, Setton LA, Grinstaff MW. Biodendrimer-based hydrogel scaffolds for cartilage tissue repair. Biomacromolecules 2006; 7: 310-6.
134. Wallace DG, Rosenblatt J. Collagen gel systems for sustained delivery and tissue engineering. Adv Drug Deliv Rev 2003; 55: 1631-49.
135. Temenoff JS, Mikos AG. Injectable biodegradable materials for orthopedic tissue engineering. Biomaterials 2000; 21: 2405-12.
136. Kim IY, Seo SJ, Moon HS, et al. Chitosan and its derivatives for tissue engineering applications. Biotechnol Adv 2008; 26: 1-21.
137. Vinatier C, Magne D, Moreau A, et al. Engineering cartilage with human nasal chondrocytes and a silanized hydroxypropyl methylcellulose hydrogel. J Biomed Mater Res A 2007; 80: 66-74.
138. Insall J. The Pridie debridement operation for osteoarthritis of the knee. Clin Orthop Relat Res 1974: 61-7.
139. Steadman JR, Rodkey WG, Briggs KK, Rodrigo JJ. [The microfracture technic in the management of complete cartilage defects in the knee joint]. Orthopade 1999; 28: 26-32.
140. Hangody L, Kish G, Karpati Z, Szerb I, Udvarhelyi I. Arthroscopic autogenous osteochondral mosaicplasty for the treatment of femoral condylar articular defects. A preliminary report. Knee Surg Sports Traumatol Arthrosc 1997; 5: 262-7.
141. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1994; 331: 889-95.
142. Magnussen RA, Dunn WR, Carey JL, Spindler KP. Treatment of focal articular cartilage defects in the knee: a systematic review. Clin Orthop Relat Res 2008; 466: 952-62.
143. Cherubino P, Grassi FA, Bulgheroni P, Ronga M. Autologous chondrocyte implantation using a bilayer collagen membrane: a preliminary report. J Orthop Surg (Hong Kong) 2003; 11: 10-5.
144. Wakitani S, Kawaguchi A, Tokuhara Y, Takaoka K. Present status of and future direction for articular cartilage repair. J Bone Miner Metab 2008; 26: 115-22.
145. Wakitani S, Imoto K, Yamamoto T, Saito M, Murata N, Yoneda M. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage 2002; 10: 199-206.
146. Centeno CJ, Busse D, Kisiday J, Keohan C, Freeman M, Karli D. Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Physician 2008; 11: 343-53.
147. Wakitani S, Nawata M, Tensho K, Okabe T, Machida H, Ohgushi H. Repair of articular cartilage defects in the patello-femoral joint with autologous bone marrow mesenchymal cell transplantation: three case reports involving nine defects in five knees. J Tissue Eng Regen Med 2007; 1: 74-9.
148. Bradham DM, Passaniti A, Horton WE, Jr. Mesenchymal cell chondrogenesis is stimulated by basement membrane matrix and inhibited by age-associated factors. Matrix Biol 1995; 14: 561-71.
149. Bulic K. Articular chondrocytes interact with basement membrane Matrigel through laminin active binding sites. Acta Med Croatica 1996; 50: 69-74.
150. Fan H, Hu Y, Li X, et al. Ectopic cartilage formation induced by mesenchymal stem cells on porous gelatin-chondroitin-hyaluronate scaffold containing microspheres loaded with TGF-beta1. Int J Artif Organs 2006; 29: 602-11.
151. Pulkkinen H, Tiitu V, Lammentausta E, et al. Cellulose sponge as a scaffold for cartilage tissue engineering. Biomed Mater Eng 2006; 16: S29-35.
152. Dounchis JS, Bae WC, Chen AC, Sah RL, Coutts RD, Amiel D. Cartilage repair with autogenic perichondrium cell and polylactic acid grafts. Clin Orthop Relat Res 2000: 248-64.
153. Yan J, Qi N, Zhang Q. Rabbit articular chondrocytes seeded on collagen-chitosan-GAG scaffold for cartilage tissue engineering in vivo. Artif Cells Blood Substit Immobil Biotechnol 2007; 35: 333-44.
154. Grad S, Kupcsik L, Gorna K, Gogolewski S, Alini M. The use of biodegradable polyurethane scaffolds for cartilage tissue engineering: potential and limitations. Biomaterials 2003; 24: 5163-71.
155. Kose GT, Korkusuz F, Ozkul A, et al. Tissue engineered cartilage on collagen and PHBV matrices. Biomaterials 2005; 26: 5187-5197.
156. Estrada LE, Dodge GR, Richardson DW, Farole A, Jimenez SA. Characterization of a biomaterial with cartilage-like properties expressing type X collagen generated in vitro using neonatal porcine articular and growth plate chondrocytes. Osteoarthritis Cartilage 2001; 9: 169-77.
157. Barbucci R, Lamponi S, Borzacchiello A, et al. Hyaluronic acid hydrogel in the treatment of osteoarthritis. Biomaterials 2002; 23: 4503-13.
158. Liao E, Yaszemski M, Krebsbach P, Hollister S. Tissue-engineered cartilage constructs using composite hyaluronic acid/collagen I hydrogels and designed poly(propylene fumarate) scaffolds. Tissue Eng 2007; 13: 537-50.
159. Sharma B, Williams CG, Khan M, Manson P, Elisseeff JH. In vivo chondrogenesis of mesenchymal stem cells in a photopolymerized hydrogel. Plast Reconstr Surg 2007; 119: 112-20.
160. Alsberg E, Anderson KW, Albeiruti A, Rowley JA, Mooney DJ. Engineering growing tissues. Proc Natl Acad Sci USA 2002; 99: 12025-30.
161. Atala A, Cima LG, Kim W, et al. Injectable alginate seeded with chondrocytes as a potential treatment for vesicoureteral reflux. J Urol 1993; 150: 745-7.
162. Elisseeff JH, Lee A, Kleinman HK, Yamada Y. Biological response of chondrocytes to hydrogels. Ann NY Acad Sci 2002; 961: 118-22.
163. Suh JK, Matthew HW. Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: a review. Biomaterials 2000; 21: 2589-98.
164. van Susante JLC, Pieper J, Buma P, et al. Linkage of chondroitinsulfate to type I collagen scaffolds stimulates the bioactivity of seeded chondrocytes in vitro. Biomaterials 2001; 22: 2359-69.
165. Taguchi T, Xu L, Kobayashi H, Taniguchi A, Kataoka K, Tanaka J. Encapsulation of chondrocytes in injectable alkali-treated collagen gels prepared using poly(ethylene glycol)-based 4-armed star polymer. Biomaterials 2005; 26: 1247-52.
166. Mercier NR, Costantino HR, Tracy MA, Bonassar LJ. A novel injectable approach for cartilage formation in vivo using PLG microspheres. Ann Biomed Eng 2004; 32: 418-29.
167. Mercier NR, Costantino HR, Tracy MA, Bonassar LJ. Poly(lactideco- glycolide) microspheres as a moldable scaffold for cartilage tissue engineering. Biomaterials 2005; 26: 1945-52.
168. Elisseeff J, Anseth K, Sims D, et al. Transdermal photopolymerization of poly(ethylene oxide)-based injectable hydrogels for tissueengineered cartilage. Plast Reconstr Surg 1999; 104: 1014-22.
169. Elisseeff J, McIntosh W, Anseth K, Riley S, Ragan P, Langer R. Photoencapsulation of chondrocytes in poly(ethylene oxide)-based semi-interpenetrating networks. J Biomed Mater Res 2000; 51: 164-71.
170. Kim TK, Sharma B, Williams CG, et al. Experimental model for cartilage tissue engineering to regenerate the zonal organization of articular cartilage. Osteoarthritis Cartilage 2003; 11: 653-64.
171. Burdick JA, Anseth KS. Photoencapsulation of osteoblasts in injectable RGD-modified PEG hydrogels for bone tissue engineering. Biomaterials 2002; 23: 4315-23.